AIMC Topic: Arylamine N-Acetyltransferase

Clear Filters Showing 1 to 1 of 1 articles

Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis.

Clinical pharmacokinetics
INTRODUCTION: Isoniazid is a first-line antituberculosis agent with high variability, which would profit from individualized dosing. Concentrations of isoniazid at 2 h (C), as an indicator of safety and efficacy, are important for optimizing therapy.